Published in AIDS Weekly, November 23rd, 1998
The results were presented at the 4th International Congress on Drug Therapy in HIV Infection, held in Glasgow, Scotland, during November 1998. The study was the first to evaluate the safety and efficacy of Agenerase in a double PI regimen in the absence of nucleoside reverse transcriptase inhibitor (NRTI) therapy.
Results of a second study presented at Glasgow suggested patients previously treated with Agenerase can be treated...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.